Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Johns Hopkins researches HIC-1-associated tumor

July 5, 1996

Zeneca reveals antiproliferative aniline derivatives

July 5, 1996

Halistatin 3: Antineoplastic agent of marine origin

July 5, 1996

Cytotoxic compound eleutherobin reported by University of California

July 5, 1996

Glaxo Wellcome describes antitumor antibody conjugates

July 5, 1996

Antitumor vaccines described by University of Pennsylvania

July 5, 1996

Human Genome Sciences reports discovery of TNF-gamma

July 5, 1996

Pharmacia & Upjohn reports taxane derivatives

July 5, 1996

Pfizer's CJ-12798 claimed as immunosuppressant, antifungal and antitumor agent

July 5, 1996

Immunostimulants claimed by Italfarmaco

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...